Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease

Table 4 Characteristics of the study population undergoing SNP genotyping

Genotype	LNN (n = 21)	LN (n = 6)	NNN (n = 37)	NN (n = 15)	ONN (n = 9)	ON (n = 44)	P value
							LN-LNN	NN-NNN	ON-ONN
SIRT1 rs2273773 TT/TC.CC	10/11	1/5	22/15	6/9	2/7	29/15	0.233	0.363	0.022
APOC3 rs2070666 TT/TA.AA	8/13	3/3	16/21	6/9	7/2	17/27	1.000	0.374	0.030
PNPLA3 rs738409 CC/CG.GG	8/13	0/6	17/20	1/14	3/6	12/32	0.370	0.014	0.237
PNPLA3 rs738408 CC/CT.TT	8/13	0/6	17/20	1/14	3/6	12/32	0.370	0.014	0.237
PNPLA3 rs4823173 GG/GA.AA	8/13	0/6	16/21	1/14	3/6	12/32	0.277	0.010	0.237
PNPLA3 rs2072906 AA/AG.GG	7/14	0/6	15/22	1/14	3/6	12/32	0.332	0.014	0.208
AGTR1 rs5186 AA/AC.CC	17/4	5/1	33/4	13/2	9/0	39/5	0.900	0.801	0.024
AGTR1 rs440881 CC/CA.AA	0/21	0/6	0/37	0/15	0/9	0/44	0.639	0.319	0.054

P values were obtained using chi-square or Kruskal-Wallis tests between different groups. NAFLD: Non-alcoholic fatty liver disease; LNN: Lean non-NAFLD; LN: Lean NAFLD; NNN: Non-obese non-NAFLD; NN: Non-obese NAFLD; ONN: Obese non-NAFLD; ON: Obese NAFLD.